MRFF 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists

Overview

The MRFF 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant is part of the Medical Research Future Fund (MRFF) and the Preventive and Public Health Research Initiative. This 4 stream program will fund organisations to undertake research to support innovative approaches to improve the quality and cost?effectiveness of preventive healthcare interventions. The objective of this program is to provide grants to Australian medical research and medical innovation projects that align with the following streams: Stream 1: assess the feasibility (including cost effectiveness, and acceptability by patients and prescribing health professionals) of pharmacogenomic interventions by community pharmacists designed to optimise medication prescription and use Stream 2: assess the feasibility (including cost effectiveness, scalability, and acceptability by patients and prescribing health professionals) of pharmacogenomic interventions to optimise the prescription and use of medicines for treating patients with cancer (oncology and supportive care) Stream 3: implement, validate, and cost approaches that involve community and hospital pharmacists collaborating to improve medication management at transition into the community Stream 4: implement, validate, and cost approaches for pharmacist interventions in residential aged care using objective patient focused indicators. The outcomes of the research funded by this grant is to improve the health and wellbeing of Australians by supporting the safe and effective use of prescription medicines, quality of care provided to patients, reducing hospital readmissions due to medication complications and evidence to support the safe and effective use of medicines in residential aged care.